A Research Study on Etavopivat in Participants With and Without Liver Disease
Clinical trial NCT06336018 · COMPLETED
Trial details
- NCT number
- NCT06336018
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2025-08-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.